Metformin in the prevention of hepatocellular carcinoma in diabetic patients: A systematic review.

CONCLUSIONS: The use of metformin was associated with a reduced risk of HCC, and it may be a relevant factor for preventing HCC in diabetic patients. PMID: 31836424 [PubMed - as supplied by publisher]
Source: Annals of Hepatology - Category: Gastroenterology Tags: Ann Hepatol Source Type: research